The Omicron variant of the CCP (Chinese Communist Party) virus can best the antibodies from Pfizer’s COVID-19 vaccine, according to a newly released small study led by South African researchers. Samples of plasma drawn from 12 people who received the Pfizer-BioNTech vaccine were tested as part of a rapid response to the variant, which recently emerged in Africa and has triggered travel bans across the world. The results? A 41-fold decline in antibodies. The research suggests the variant “escapes antibody immunity induced by the Pfizer-BioNTech vaccine,” the Africa Health Research Institute said. Several scientists with the research, based in Durban, collaborated on the study with other researchers in Africa. Researchers did find evidence that those who were vaccinated and had recovered from COVID-19 saw less of a reduction in protection. “Previous infection + vaccination still neutralizes,” Alex Sigal, one of the researchers, wrote on Twitter. It was not clear why unvaccinated persons …